These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3595686)

  • 1. Altered growth control by natural growth inhibitors in the mutant HD33 substrain of the Ehrlich-Lettré ascites mammary carcinoma.
    Lehmann W; Böhmer FD; Karsten U; Graetz H; Koberling A; Kunde D; Langen P
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):69-74. PubMed ID: 3595686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and growth kinetics of the mutant Ehrlich-Lettré ascites cell strain HD33 in permanent suspension culture.
    Granzow C; Granzow V; Edler L; Sauer W
    Cell Tissue Kinet; 1986 May; 19(3):245-55. PubMed ID: 3719659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
    Böhmer FD; Lehmann W; Schmidt HE; Langen P; Grosse R
    Exp Cell Res; 1984 Feb; 150(2):466-76. PubMed ID: 6363109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of a chalone-like inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
    Lehmann W; Samtleben R; Graetz H; Langen P
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):101-7. PubMed ID: 6221930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of colchicine resistance in Ehrlich-Lettré ascites tumors and cell strains.
    Granzow C
    J Cancer Res Clin Oncol; 1981; 102(1):57-69. PubMed ID: 7334053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth dependence of nuclear glycogen synthesis in mutant HD33 Ehrlich-Lettré ascites tumor cells.
    Kopun M; Granzow C
    Cell Mol Biol; 1985; 31(3):181-93. PubMed ID: 4016835
    [No Abstract]   [Full Text] [Related]  

  • 9. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland?
    Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R
    Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
    Lehmann W; Widmaier R; Langen P
    Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of proliferation of Ehrlich ascites carcinoma cells is functionally correlated with reduced activity of the cytosol to stimulate protein synthesis.
    Bielka H; Grosse R; Böhmer F; Junghahn I; Binas B
    Biomed Biochim Acta; 1986; 45(4):441-5. PubMed ID: 3707560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of membrane-associated growth inhibitor activity for Ehrlich ascites mammary carcinoma cells.
    Herrmann I; Grosse R
    Biomed Biochim Acta; 1986; 45(4):447-57. PubMed ID: 3010958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of DNA synthesis in the parotid salivary gland of adult mice by a factor isolated from acellular fluid of the Ehrlich ascites carcinoma.
    Burns ER; Yeh HW; Yeh YC
    Biosci Rep; 1983 Feb; 3(2):113-25. PubMed ID: 6850077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of honey and eugenol on Ehrlich ascites and solid carcinoma.
    Jaganathan SK; Mondhe D; Wani ZA; Pal HC; Mandal M
    J Biomed Biotechnol; 2010; 2010():989163. PubMed ID: 20369055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-limitation of ascites tumor growth: a possible chalone regulation.
    Bichel P
    Natl Cancer Inst Monogr; 1973 Jul; 38():197-203. PubMed ID: 4271044
    [No Abstract]   [Full Text] [Related]  

  • 16. Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.
    Zardi L; Cecconi C; Barbieri O; Carnemolla B; Picca M; Santi L
    Cancer Res; 1979 Sep; 39(9):3774-9. PubMed ID: 383288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
    Lehmann W; Graetz H; Schütt M; Langen P
    Acta Biol Med Ger; 1977; 36(7-8):K 43-52. PubMed ID: 148196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublines of the Ehrlich-Lettré mouse ascites tumour. A new tool for experimental cell research.
    Lettré R; Paweletz N; Werner D; Granzow C
    Naturwissenschaften; 1972 Feb; 59(2):59-63. PubMed ID: 5015750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of adrenaline on the mitosis-inhibiting action of a chalone-containing preparation in Ehrlich ascites tumor].
    Romanov IuA; Ivchenko TN; Sultanova ZF
    Biull Eksp Biol Med; 1988 Mar; 105(3):345-7. PubMed ID: 2964881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nuclear glycogen synthase and cytoplasmic UDP glucose pyrophosphorylase in the biosynthesis of nuclear glycogen in HD33 Ehrlich-Lettré ascites tumor cells.
    Granzow C; Kopun M; Zimmermann HP
    J Cell Biol; 1981 Jun; 89(3):475-84. PubMed ID: 6265468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.